Kodiak Sciences Inc (KOD)
3.94
+0.17
(+4.51%)
USD |
NASDAQ |
May 06, 16:00
3.95
+0.01
(+0.25%)
After-Hours: 20:00
Kodiak Sciences Total Assets (Quarterly): 479.37M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 479.37M |
| September 30, 2023 | 547.65M |
| June 30, 2023 | 589.66M |
| March 31, 2023 | 640.33M |
| December 31, 2022 | 666.63M |
| September 30, 2022 | 723.99M |
| June 30, 2022 | 781.90M |
| March 31, 2022 | 850.29M |
| December 31, 2021 | 904.22M |
| September 30, 2021 | 958.21M |
| June 30, 2021 | 997.60M |
| March 31, 2021 | 1.033B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.067B |
| September 30, 2020 | 480.74M |
| June 30, 2020 | 429.37M |
| March 31, 2020 | 443.04M |
| December 31, 2019 | 358.87M |
| September 30, 2019 | 68.92M |
| June 30, 2019 | 78.28M |
| March 31, 2019 | 87.08M |
| December 31, 2018 | 92.19M |
| September 30, 2018 | 17.12M |
| June 30, 2018 | 21.70M |
| December 31, 2017 | 3.244M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
68.92M
Minimum
Sep 2019
1.067B
Maximum
Dec 2020
636.80M
Average
640.33M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 20.99M |
| Regeneron Pharmaceuticals Inc | 34.37B |
| iBio Inc | 34.02M |
| Puma Biotechnology Inc | 214.15M |
| Dare Bioscience Inc | 21.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 213.59M |
| Shareholders Equity (Quarterly) | 265.78M |